SCHEMBL19367484

SCHEMBL19367484

Cc1cc(C(=O)CC#N)cc(Br)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.39
ALDH1A1 P00352 8/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C19 P33261 3/20 0.38
POLB P06746 1/20 0.38
CYP2C9 P11712 1/20 0.38
MAPT P10636 4/20 0.37
HTT P42858 4/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.35
CYP2D6 P10635 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 2/20 0.34
KDM4E B2RXH2 2/20 0.34
RECQL P46063 2/20 0.34
HPGD P15428 1/20 0.34
ALPL P05186 1/20 0.32
ALPG P10696 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28010208 0.88 ALDH1A1 (0.41) KCNH2ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL17607834 0.81 ALDH1A1 (0.44) KCNH2ALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL4927775 0.73 NPC1 (0.43) MAPTHTTLMNAGAAKDM4E
SCHEMBL31750445 0.73 TPMT (0.46) ALDH1A1POLBHTT
SCHEMBL2564827 0.73 TPMT (0.46) ALDH1A1POLBHTT
SCHEMBL4850442 0.73 TPMT (0.46) KCNH2ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL2686060 0.72 KCNH2 (0.38) KCNH2ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL3118332 0.72 POLB (0.43) ALDH1A1CYP1A2CYP3A4POLBHTT
SCHEMBL11240574 0.71 ALDH1A1 (0.39) ALDH1A1CYP1A2CYP3A4CYP2C19POLB
SCHEMBL19367482 0.71 HTT (0.49) ALDH1A1MAPTHTTUSP2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170267656-A1 PYRAZOLYL-SUBSTITUTED PYRIDONE COMPOUNDS AS SERINE PROTEASE INHIBITORS VERSEON INTERNATIONAL CORPORATION 2017-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267656-A1 PYRAZOLYL-SUBSTITUTED PYRIDONE COMPOUNDS AS SERINE PROTEASE INHIBITORS SERPINE1, PRSS1, SPINT2 KCNH2 2308/4885ALDH1A1 3248/4885CYP1A2 1647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.